Immunotherapy for Recurrent Glioblastoma Multiforme: Enhancing...

Immunotherapy for Recurrent Glioblastoma Multiforme: Enhancing Recurrent Glioblastoma Multiforme Treatment Efficacy

Posted 2023-05-15 12:35:41

Nanotechnology has opened up new possibilities in targeted drug delivery and imaging for Recurrent Glioblastoma Multiforme Treatment. Nanoparticles can be designed to carry therapeutic agents specifically to tumor sites, reducing systemic toxicity and improving drug efficacy. Additionally, nanotechnology-based imaging techniques offer high-resolution and real-time visualization of tumor progression and treatment response. These advancements aid in the accurate assessment of treatment outcomes and facilitate personalized treatment plans for recurrent GBM patients.

TTFields therapy is a novel treatment modality that utilizes low-intensity alternating electric fields to disrupt cell division and inhibit tumor growth. This therapy involves the application of electric fields directly to the patient's scalp via a device that generates non-thermal electric fields. Clinical trials have demonstrated the efficacy of TTFields in both newly diagnosed and recurrent GBM. The therapy has shown an improvement in progression-free survival and overall survival rates in recurrent GBM patients when used in combination with chemotherapy.